EN
HI
Lupin Chart
Lupin Share Key Metrics
Volume
2637.00
Market Cap
106664.75 CR
LTQ@LTP
5@2333.80
ATP
0
Var Margin
12.66 %
Circuit Range
2100.5-2567.1
Delivery %
67.81 %
Value
0.00
ASM/GSM
No
Market Lot
1
Summary
At 13 Apr, 2026 | 09:03, Lupin share price stands at ₹2333.8, showing a 0.00% 0.00 for the day. The stock’s intraday movement has stayed between ₹00 and ₹00, while on a 52-week basis it has fluctuated from ₹1836.80 to ₹2377.60.
In terms of trading activity, Lupin has recorded a volume of 2637 shares, with a market capitalisation of ₹457043219. The stock’s Average Traded Price (ATP) stands at ₹, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5,233380. The stock operates within a circuit range of ₹2100.5-2567.1, with a Value of ₹0.00. The Delivery Percentage for the day is 67.81%. Additionally, Lupin currently falls under the No framework, and trades with a market lot size of 1.
Lupin Fundamentals
View MoreP/E Ratio
22.96
P/B Ratio
5.12
Div. Yield
0.51
Sector P/E
62.92
Sector P/B
3.41
Sec. Div. Yield
0.57
Lupin Resistance and Support
Pivot 2320.1
Resistance
First Resistance
2350.1
Second Resistance
2366.4
Third Resistance
2396.4
Support
First Support
2303.8
Second Support
2273.8
Third Support
2257.5
Lupin Futures & Options
Lupin Option Chain
View Price, OI, Greeks & More...
28APR26
2335.10
-1.60 (0.07%)
26MAY26
2350.00
2.00 (0.09%)
30JUN26
2347.20
0.00 (0.00%)
LUPIN|28APR26 CE 2320.00
58.50
0.05 (0.09%)
LUPIN|28APR26 PE 2340.00
52
0.2 (0.39%)
Lupin Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results & Others |
Lupin News
Lupin Limited
Lupin launched Dapagliflozin Tablets, 5 mg and 10 mg, in the United States. This product received U.S. FDA approval, confirming its bioequivalence to Farxiga® and bolstering Lupin's presence in the anti-diabetic market.
Apr 10 2026 19:04:00
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin secured US FDA approval for its Abbreviated New Drug Application (ANDA) for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets. This approval is for various strengths and makes the product bioequivalent to Xigduo® XR.
Apr 08 2026 17:04:00
Read More
About Lupin
NSE : 10440
BSE : 500257
ISIN : INE326A01037
Lupin Management
| Name | Position |
|---|---|
| Mrs. Manju D Gupta | Chairperson |
| Mr. Nilesh D Gupta | Managing Director |
Lupin Similar Stocks
Sun Pharmaceutical Industries Ltd.
1655.00
0.10 (0.01%)
Divi's Laboratories Ltd.
6120.00
3.50 (0.06%)
Torrent Pharmaceuticals Ltd.
4146.00
-9.20 (0.22%)
Apollo Hospitals Enterprise Ltd.
7519.50
8.00 (0.11%)
Dr. Reddy's Laboratories Ltd.
1229.70
-2.50 (0.20%)
Cipla Ltd.
1230.80
1.30 (0.11%)
Lenskart Solutions Ltd.
547.15
-0.40 (0.07%)
Max Healthcare Institute Ltd.
957.00
3.65 (0.38%)
Zydus Lifesciences Ltd.
915.90
0.50 (0.05%)
Mankind Pharma Ltd.
2084.00
5.00 (0.24%)
Lupin FAQs
The Buying Price of Lupin share is 2333.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lupin stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lupin, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lupin shares is 22.96. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lupin shares is 5.12. Useful to assess the stock's value relative to its book value.
To assess Lupin’s valuation compare Sector P/E, P/B which are 62.92 & 3.41 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lupin is 106664.75 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lupin share price is 2377.60 & 1836.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lupin belongs to the Healthcare sector.
